Join the Triamcinolone group to help and get support from people like you.
Triamcinolone News
Related terms: Triamcinolone Topical, Triamcinolone Nasal, Triamcinolone Ophthalmic
FDA Approves Xipere (triamcinolone acetonide injectable suspension) for the Treatment of Macular Edema Associated with Uveitis
LAVAL, QC and ALPHARETTA, Ga., Oct. 25, 2021 /PRNewswire/ – Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), and Clearside...
FDA Medwatch Alert: Compounded Products Containing Triamcinolone-Moxifloxacin by Guardian Pharmacy Services (Dallas, Texas): Alert to Health Professionals - Adverse Events After Receiving Eye Injections
ISSUE: At least 43 patients reported adverse events after receiving eye injections of Guardian’s Pharmacy Services compounded triamcinolone-moxifloxacin product during cataract surgery. The patients ...
Flexion Therapeutics Announces FDA Approval of Zilretta (triamcinolone acetonide extended-release injectable suspension) for Osteoarthritis Knee Pain
BURLINGTON, Mass., Oct. 06, 2017 (GLOBE NEWSWIRE) – Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that the U.S. Food and Drug Administration (FDA) approved Zilretta (triamcinolone...
FDA Medwatch Alert: Epidural Corticosteroid Injection: Drug Safety Communication - Risk of Rare But Serious Neurologic Problems
Including methylprednisolone, hydrocortisone, triamcinolone, betamethasone, and dexamethasone [Posted 04/23/2014] ISSUE: FDA is warning that injection of corticosteroids into the epidural space of...
FDA Approves Sanofi's Nasacort Allergy 24HR for Over-the-Counter Use
Paris, France, October 11, 2013 — Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Nasacort Allergy 24HR nasal spray as an over-the-counter (OTC) treatment for s...
FDA Medwatch Alert: Fungal Meningitis Outbreak
[UPDATE 10/24/2012] The updated list of customers (consignees) who were shipped product on or after May 21, 2012 from the New England Compounding Center’s (NECC) Framingham, MA facility is now pos...
FDA Medwatch Alert: Fungal Meningitis Outbreak
FDA provides NECC Customer List [UPDATE 10/22/2012] FDA is making available two lists of customers (consignees) who received products that were shipped on or after May 21, 2012 from New England ...
FDA Medwatch Alert: FDA Statement on Fungal Meningitis Outbreak: Additional Patient Notification Advised
[Update 10/16/2012] On 10/15/12 the health care facility notified CDC that the initial report of two transplant patients has been revised to one patient who received cardioplegia solution from NECC....
FDA Medwatch Alert: FDA Statement on Fungal Meningitis Outbreak: Additional Patient Notification Advised
ISSUE: As a result of the ongoing investigation of New England Compounding Center (NECC), a patient with possible meningitis potentially associated with epidural injection of an additional NECC...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Allergic Reactions, Hay Fever, Allergic Rhinitis, Alopecia, Allergies, Bursitis, Dermatological Disorders, Osteoarthritis, Lichen Sclerosus, view more... Systemic Lupus Erythematosus, Leukemia, Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Lichen Planus, Ankylosing Spondylitis, Asthma, Dermatitis, Frozen Shoulder, Heart Failure, Congestive Heart Failure, Inflammatory Conditions